Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Kardiologiia ; 50(7): 38-42, 2010.
Article in Russian | MEDLINE | ID: mdl-20659043

ABSTRACT

We determined parameters of elasticity of peripheral arteries in patients with heart failure (HF) including those with pulmonary arterial hypertension. We also investigated pulmonary artery responses to vasoconstricting factors in vitro. Reactivity of the aorta and carotid artery was studied on the model of experimental HF. Lowering of elasticity of small arteries progressed with worsening of HF functional class and increase of pulmonary arterial hypertension. In the genesis of pulmonary hypertension definite role played elevated constrictor response of pulmonary artery to endothelin 1 at the background of dysfunction of endothelial ETB receptors. Endothelial dependent reactivity of the aorta and carotid artery was impaired and their constrictor effect augmented.


Subject(s)
Elasticity , Heart Failure/physiopathology , Hypertension, Pulmonary/physiopathology , Vascular Resistance/drug effects , Comorbidity , Disease Progression , Endothelin B Receptor Antagonists , Endothelin-1/pharmacology , Endpoint Determination , Heart Failure/epidemiology , Humans , Hypertension, Pulmonary/epidemiology , Pulmonary Artery/physiopathology , Receptor, Endothelin B/drug effects , Vasoconstrictor Agents/pharmacology
2.
Kardiologiia ; 45(8): 33-6, 2005.
Article in Russian | MEDLINE | ID: mdl-16091638

ABSTRACT

Despite obvious participation of endothelins in pathogenesis of heart failure therapeutic approaches to the use of endothelin receptor antagonists remain to be elucidated. Experimental heart failure caused by prolonged infusion of norepinephrine is associated with diminished endothelin induced coronary constricting effect of stimulation of ET(A) receptors and inversion of coronary dilating effect of stimulation of these receptors. The latter effect is mediated by smooth muscle ET(B)-receptors and is indicative of functional derangement of vascular control by endothelial cells. The use of selective ET(A)-antagonist is effective on early stages of heart failure while on later stages administration of nonselective ET(AB)-antagonist produces more pronounced effect.


Subject(s)
Endothelium, Vascular/physiopathology , Heart Failure/physiopathology , Vasoconstriction/physiology , Ventricular Function, Left/physiology , Animals , Antihypertensive Agents/therapeutic use , Aorta, Thoracic/drug effects , Aorta, Thoracic/physiopathology , Coronary Vessels/drug effects , Coronary Vessels/physiopathology , Disease Models, Animal , Endothelin Receptor Antagonists , Endothelium, Vascular/drug effects , Heart Failure/chemically induced , Heart Failure/drug therapy , In Vitro Techniques , Norepinephrine/toxicity , Oligopeptides/therapeutic use , Peptides, Cyclic/therapeutic use , Rats , Vasoconstriction/drug effects , Ventricular Function, Left/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...